U.S. Electric Utilities Stock News

Motorola Solutions (MSI) is back in the spotlight after teaming up with Google to let Android users stream live video directly to 911 call handlers, a practical upgrade to its already entrenched public safety platform. See our latest analysis for Motorola Solutions. That kind of real world innovation is arriving just as sentiment is resetting. The latest 1 day share price return of 2.93 percent has lifted Motorola Solutions to 374.49 dollars after a tough stretch that has seen a 90 day share...

In early December 2025, Medtronic’s board approved a US$0.71 per-share cash dividend for the third quarter of fiscal 2026, payable on January 16, 2026, to shareholders of record as of December 26, 2025. More recently, Medtronic gained FDA approval for its Hugo robotic-assisted surgery system and began the U.S. commercial launch of the MiniMed 780G with Abbott’s Instinct sensor, signaling continued investment in advanced robotics and diabetes technology. We’ll now examine how the FDA-cleared...

Atmos Energy (ATO) shares have quietly climbed over the past year, with the stock up about 27% and roughly 22% year to date, prompting a closer look at what is driving the move. See our latest analysis for Atmos Energy. With the share price now around $169.17 and a strong year to date share price return, that 1 year total shareholder return near 27% suggests investors are steadily repricing Atmos for dependable growth rather than treating it as a sleepy utility. If this steady climb in a...

Semtech (SMTC) shares have quietly pulled back about 6% in the past day and 16% over the past week, even though the stock is still up this month and in the past 3 months. See our latest analysis for Semtech. Viewed over a longer stretch, Semtech’s recent pullback sits against a still positive backdrop, with an 8.1% year to date share price return and a hefty 148.45% three year total shareholder return suggesting momentum is cooling rather than broken. If you are weighing what comes next for...

State Street (STT) has quietly put up a solid run, with shares gaining roughly 30% this year and about 12% over the past 3 months, as earnings and margin trends keep improving. See our latest analysis for State Street. At a share price of $127.36, State Street’s momentum looks like it is still building, with a 30 day share price return of 12.51% feeding into a 37.64% one year total shareholder return and an 81.17% total shareholder return over three years. If this kind of steady compounding...

In the past week, J.P. Morgan downgraded Ingram Micro Holding to “underweight,” citing concerns about weaker enterprise IT spending and a likely cooling in PC demand after a strong 2025 cycle. This shift in analyst sentiment contrasts with Ingram Micro’s recent AWS Partner of the Year awards and its new Polish go-to-market collaboration for SaaS data protection. We’ll now examine how J.P. Morgan’s downgrade and concerns around enterprise spending shape Ingram Micro’s investment...

Richtech Robotics (RR) has quietly become one of the more volatile small cap robotics names, with the stock swinging sharply over the past week despite relatively steady fundamentals and a still early stage revenue base. See our latest analysis for Richtech Robotics. That volatility sits on top of a wild ride over the past year, with a roughly 42% year to date share price return but an eye catching 198% one year total shareholder return suggesting momentum is still broadly intact even after...

In December 2025, activist investor Engine Capital, backed by proxy advisers and fellow shareholders, won majority common-shareholder support for its UniFirst board nominees, intensifying pressure on the company to address governance concerns and consider a potential sale. The vote exposed a sharp divide between UniFirst’s dual-class control structure and the preferences of common shareholders, who are increasingly pushing for an independent strategic review and greater accountability from...

In recent days, Amkor Technology has come under pressure after insider selling, including a large block sale by a director, coincided with softer near-term earnings expectations despite projected double-digit revenue growth. At the same time, the company is committing to a very large US$7.00 billion advanced packaging campus in Arizona, underscoring its role in the onshoring of semiconductor manufacturing as AI and data center demand reshape global chip supply chains. Against this backdrop,...

In December 2025, Brookdale Senior Living Inc. reported that November consolidated weighted average occupancy reached 82.5%, rising 300 basis points year-over-year but slipping 10 basis points from October, with similar patterns in same-community occupancy and an 80 basis point improvement for fourth quarter to date versus the full third quarter of 2025. An interesting element for investors is that November’s small sequential occupancy decline was consistent with Brookdale’s typical seasonal...

In December 2025, REX American Resources reported third-quarter results showing sales of US$175.63 million and net income of US$23.41 million, with diluted earnings per share from continuing operations at US$0.71, slightly above the prior year. However, for the first nine months of the fiscal year, net income declined to US$39.20 million even as sales edged up to US$492.53 million, highlighting pressure on profitability. With third-quarter earnings per share roughly flat year over year,...

California Water Service Group (CWT) has been quietly grinding through a choppy year, with the stock slipping over the past 3 months even as revenue and net income continue to grow at a steady clip. See our latest analysis for California Water Service Group. The recent pullback, including a 30 day share price return of minus 3.3 percent and a 90 day share price return of minus 3.6 percent, sits on top of a much tougher three year total shareholder return of minus 23.3 percent. This suggests...

In recent days, Inspire Medical Systems has faced renewed attention as regulators finalized a substantial future increase in Medicare facility fees for its sleep apnea procedure, while multiple law firms advanced securities class actions tied to the rollout of its Inspire V device. This combination of richer long-term reimbursement and heightened legal and execution scrutiny creates a complex risk–reward backdrop for investors assessing Inspire’s path forward. Now we’ll explore how the...

Bit Digital, Inc. recently disclosed that director Xiashu “Bill” Xiong will resign effective January 1, 2026, while long-time chair Zhaohui Deng shifted to an independent director role and the board appointed crypto executive Amanda Cassatt for a one-year term starting the same day. These boardroom moves coincide with Bit Digital’s expanding Ethereum holdings and staking activity, sharpening investor focus on how fresh governance and crypto expertise might shape the company’s evolving...

On December 5, 2025, Graco Inc. announced a 7.3% increase in its regular quarterly dividend to US$0.295 per share, payable on February 4, 2026, and unveiled a new repurchase authorization for up to 15,000,000 shares with no set expiry. By simultaneously raising its cash payout and committing to a large, open-ended buyback, Graco is signaling confidence in its balance sheet and willingness to return more capital directly to shareholders. Next, we’ll examine how Graco’s larger quarterly...

Dropbox, Inc. announced that longtime finance chief Timothy Regan has stepped down as CFO after five years in the role, with former Avalara president and ex-CFO Ross Tennenbaum taking over on December 16, 2025, as Regan remains at the company in a non-executive capacity until March 15, 2026. This leadership change comes as Dropbox increases spending on artificial intelligence, including its Dropbox Dash tool that links services like Google Workspace and Slack to organize and search files...

Earlier in December 2025, CVS Health raised its 2025 guidance to at least US$400.00 billion in revenue and higher GAAP operating income, while also flagging an expected US$5.73 billion goodwill impairment tied to its health care delivery assets. The combination of upgraded guidance and a very large non-cash impairment highlights how CVS is resetting reported earnings while doubling down on value-based care and its Healthy 2030 sustainability agenda. We’ll now examine how this mix of higher...

Earlier this month, The Progressive Corporation’s board declared a quarterly dividend of US$0.10 per share and a much larger annual dividend of US$13.50 per share, both payable on January 8, 2026, to shareholders of record on January 2, 2026. These dividend decisions came alongside November 2025 results showing double‑digit growth in net premiums written and earned, plus an 87.1 combined ratio that underscores currently efficient underwriting. With this strong premium growth and underwriting...

SL Green Realty Corp. recently announced that its board declared a regular quarterly cash dividend of US$0.40625 per share on its Series I Preferred Stock for the period from October 15, 2025 to January 14, 2026, payable on January 15, 2026 to shareholders of record as of December 31, 2025. Alongside this, the company reported signing 2.3 million square feet of Manhattan office leases so far in 2025, with a further 1.2 million square feet in its pipeline, underscoring how active leasing...

Market context and recent performance Nektar Therapeutics (NKTR) has quietly turned into a high volatility story stock, with shares up more than 200% over the past year even as the past month has been choppy. See our latest analysis for Nektar Therapeutics. That surge has come with a reality check, as the 30 day share price return of negative 23.22% and recent weekly pullback suggest some speculative heat is cooling even though the 1 year total shareholder return remains exceptionally...

In early December 2025, Olympus, W. L. Gore & Associates, and CONMED announced that US distribution of the GORE VIABIL biliary stent will shift from CONMED to Olympus on January 1, 2026, as CONMED accelerates the end of its Gore distribution agreement. At the same time, CONMED confirmed it will exit its gastroenterology product lines to focus resources on minimally invasive, robotic, and orthopedic soft tissue surgery, aligning its portfolio more tightly with its core areas. Now, we will...

Kimbell Royalty Partners, LP recently completed its Fall 2025 borrowing base redetermination and entered a Second Amended and Restated Credit Agreement, extending its secured revolving credit facility’s maturity to December 16, 2030, reaffirming a US$625 million borrowing base, cutting interest spreads by 35 basis points, and lifting the maximum facility size to US$1.50 billion. The unanimous support from existing lenders, combined with lower borrowing costs and looser covenants, signals...

Earlier this week, Wedbush initiated coverage on Rithm Capital Corp. with an Outperform rating, pointing to its valuation, consistent dividend history, and the recent Crestline Management acquisition that lifted its investable assets to about US$102 billion. The endorsement also drew attention to the firm’s growing investment advisor arm and expansion in alternative lending, reinforcing Rithm’s push to become a broader real-asset and credit manager rather than a traditional mortgage REIT...

WesBanco (WSBC) has quietly put together a solid run, with the stock up roughly 16% over the past month. That climb comes alongside double digit revenue and earnings growth and is drawing fresh attention to its valuation. See our latest analysis for WesBanco. Zooming out, WesBanco’s 30 day share price return of about 16% has helped lift year to date gains and sits alongside a five year total shareholder return of roughly 47%. This suggests momentum is building as investors warm to its growth...